Sanofi releases Q1 2026 financial modelling support document

Sanofi announced on March 24, 2026, that its Q1 2026 aide-mémoire is now available. The document, designed to support financial modelling of quarterly results, can be found on the company's website under the "Investors" section.

The aide-mémoire provides details on non-comparable items, foreign currency impact, and share count. This release of preliminary data is part of Sanofi's ongoing commitment to transparency with its stakeholders and aids in the analysis of its financial performance.

Sanofi's official Q1 2026 results are scheduled to be published on April 23, 2026. This staggered release of information allows analysts and investors time to integrate the detailed modelling data into their assessments ahead of the full earnings report.

Sanofi is a global biopharmaceutical company focused on research and development to improve people's lives. The company develops and markets a range of medicines and vaccines.